• More than 60% of American who suffer from mental health conditions want access to psychedelic options
• Growing number of cities, states looking at decriminalizing use of psychedelic medicine
• Cybin is working with world-class partners, internationally recognized scientists to create safe, effective therapeutics in the mental-health space

The awareness of psychedelics and the potential for treating an array of mental health diseases is growing, as evidenced by a recent survey reporting that 65% of affected Americans want access to psychedelics for potential treatment (https://ibn.fm/jIV2K). Those are numbers that Cybin (NEO: CYBN) (NYSE American: CYBN), a leading ethical biopharmaceutical company, is paying close attention to. “Respondents who self-reported that they suffer from a mental health condition say that psychedelic medicine, including ketamine, psilocybin mushrooms, and MDMA, should be made available to patients with treatment-resistant anxiety, depression, or PTSD,” a recent “Forbes” article reported. The article noted that the pandemic has skyrocketed the need for psychedelic wellness, with society reaching a “tipping point where the data and science regarding psychedelic therapies have become undeniable in treating a variety of serious conditions.” The article went on to explain that ketamine is legal in the United States for medical use; the substance is an FDA-approved anesthetic that can be prescribed for a myriad of ailments in a regulated setting by licensed clinicians. “Psilocybin, like cannabis, is still considered a Schedule 1 drug in the eyes of the federal government,” the article continued. “Therefore, its sale and use are illegal, despite some states and cities that have begun to decriminalize mushrooms. Beginning in 2019, psilocybin has been decriminalized in Denver, Oregon, and Santa Cruz. The state of California even has a measure on the 2022 ballot that would decriminalize psychedelic medicine in the state.” Clearly the tide is changing as popular opinion is swinging in favor of the powerful potential of psychedelics. A pioneer in the space, Cybin saw the writing on the wall long ago and has been actively working to establish itself as a leader in the psychedelic arena. Currently the company has three active drug programs targeting major depressive disorder, alcohol use disorder, anxiety disorders and neuroinflammation, as well as 50 novel compounds developed with more than 10 patent filings across three patent families (https://ibn.fm/VKH0T). In terms of investor interest, Cybin has raised $120 million to date to support its clinical trials and M&A strategy. In addition, the company is working with a network of world-class partners and internationally recognized scientists to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in the United States, the United Kingdom and Ireland. The company is focused on progressing psychedelics to therapeutics by engineering proprietary drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens for mental health disorders. For more information, visit the company’s website at www.Cybin.com. NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

• The global surveillance video market is projected to hit $70 billion in revenue by 2026
• A violent crime occurs every 26.2 seconds and a property crime every 4.4 seconds in the United States
• Knightscope looks to tap into this existing opportunity with its Autonomous Security Robots (“ASRs”)
• With an annual subscription of just $4-$9 per hour, the company offers clients significant savings, in addition to increased security using the most advanced surveillance technology with unrivaled efficiency and effectiveness

The United States of America has invested heavily in equipping its troops with the latest and greatest technology. However, first responders have not been afforded the same level of attention and support. Today, it is estimated that there are over one million security guards in the country, over a million law enforcement professionals, 8000 private security firms, and over 19,000 law enforcement agencies. However, a violent crime occurs every 26.2 seconds, with property crimes occurring every 4.4 seconds. The job of providing security to people and businesses operating in 50 different states currently falls largely on a limited and costly base of human providers (https://ibn.fm/369jW). With these statistics, there is a need to revisit the security situation, with surveillance representing the critical first step in the overall security process. It is clear that the capacity with the current workforce to offer reliable security surveillance is severely wanting. However, there is a new and effective solution to this problem. Knightscope (NASDAQ: KSCP) is already blazing the trail in this sector. With its autonomous security solutions, this company is working towards solving critical human resource issues plaguing the security sector, a step toward realizing Knightscope’s stated mission of making the United States the safest country in the world. The company is a key developer and provider of Autonomous Security Robots (“ASRs”), technology that offers cost-effective 24/7/365 security in places where people study, visit, work, and live. These high-tech security patrolling robots are available to clients on a subscription basis, and its client list already comprises multiple Fortune 1000 companies, public institutions, and commercial business operations, among others. One of Knightscope’s primary selling points is the cost associated with the products and services it delivers. Its model features an annual subscription that ranges between $4 and $9 per hour. In addition, the service is all-inclusive, allowing clients to focus on their operations, knowing that the security aspect of their work is taken care of by Knightscope (https://ibn.fm/OQLaW). For comparison, human guarding costs an average of $17.5 an hour, bringing monthly expenses, for a single guard, to $12,775. With Knightscope, business owners’ security expenditure can range between $2,038 to $6,570, coupled with a 0% turnover rate and perks that include, but are not limited to, advanced detection capabilities and increased overall efficiency. With a single subscription, Knightscope clients enjoy deployment of the ASRs, the technology that comes both with the robots and the company’s security operations center for full communication and control, as well as after-sales services. Clients also get to enjoy unlimited software, firmware, and hardware upgrades, guaranteeing their security operations’ overall effectiveness and efficiency. It is projected that by 2026, the global surveillance video market will achieve $70 billion in revenue, representing a CAGR of 10.2% over the forecast period (2021-2026). This will be primarily attributed to the growing use of thermal cameras, smart city devices, and the Internet of Things (“IoT”). Knightscope recognizes this opportunity and is positioning itself to capitalize on this growth (https://ibn.fm/yrPiR). As a company pushing the limits of technology and artificial intelligence in the security space, Knightscope understands better than anybody the potential and the financial opportunity. The company is offering value not just to its clients but also to its shareholders while continuing to make the country safer. For more information, visit the company’s website at www.Knightscope.com. NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

• Metabolic disease cases rising globally, diseases include diabetes, dementia, cardiovascular conditions, stroke
• Companies in diagnostic space posting record revenues, double-digit YOY increases
• Nemaura Medical aims to disrupt the market with Mikobo program’s non-invasive sensor technology, companion mobile application and coaching programs
• Competitor devices use microneedles coated with enzymes and polymers that can cause discomfort, trauma, and skin changes

Clinical research reveals that volatile blood sugar fluctuations are a primary risk factor for rapidly rising cases of metabolic syndrome – a cluster of diseases that include diabetes, dementia, cardiovascular issues, and stroke. Abbott (NYSE: ABT), a global healthcare company targeting the space, recently posted 4Q21 record revenue of $1.02 billion for its FreeStyle Libre diagnostic product, a 35% YOY increase. Nemaura Medical (NASDAQ: NMRD), a medical technology company that develops affordable diagnostic and digital tools for chronic disease management, is strongly positioned to take a substantial market share with its recently launched Mikobo metabolic health and wellness program, offering a distinct competitive advantage with AI-powered monitoring devices that are non-invasive, easy to wear, and cost-effective. Sensors developed by Nemaura stand apart from competitor devices that employ microneedles coated with enzymes and polymers – some of which require insertion for up to five days. Besides causing discomfort upon insertion, users report trauma and bruising in addition to changes to the skin surface. In contrast, Nemaura Medical’s sugarBEAT(R) and proBEAT(TM) Continuous Glucose Monitors (“CGMs”) sit on the surface of the skin, are easy to apply, and can be worn comfortably without the need for extended periods of wear, providing real-time insights into a person’s state of metabolic health, dietary guidance, and exercise recommendations with the aim of improved long term health and wellness, potentially avoiding many of the chronic conditions that can arise from poor metabolic health. “A person’s response to sugar intake can influence a number of factors from appetite and body weight to sleep patterns, energy levels, and even mood, not to mention also being a considerable factor in chronic diseases like diabetes, heart disease and dementia,” said Nemaura CEO Dr. Faz Chowdhury. “With MiBoKo, we are able to extend our proprietary non-invasive device and sensor technology and interactive lifestyle and AI-based coaching programs beyond the traditional diabetes market and into an adjacent, yet separate, market application of consumer metabolic health.” According to Harvard Health, metabolic syndrome cases are rising – especially among women, young adults, Asian, and Hispanic populations. Besides causing multiple health issues among vulnerable groups, employers and insurers are burdened with rising health expenses. According to the International Diabetes Federation, estimates for diabetes expenses – one of many conditions caused by metabolic syndrome – topped $966 billion in 2021, a 316% increase from 15 years ago. “At Nemaura, we continue to look for the intersection of patient comfort and convenience through advanced and unique technology that addresses significant healthcare needs for large patient populations,” said Dr. Chowdhury. “We believe that MiBoKo offers insights into metabolic health in a user-friendly way unlike any other program on the market.” Nemaura’s novel technology could potentially help avoid or delay the onset of conditions such as diabetes, heart disease, and other conditions resulting from poor metabolic health. With a strong position at the intersection of the Type 2 diabetes, weight loss health tech, and prediabetic markets, Nemaura management strongly believes that MiBoKo will positively impact populations affected by diseases caused by poor blood sugar management. For more information, visit the company’s website at www.NemauraMedical.com. NOTE TO INVESTORS: The latest news and updates relating to NMRD are available in the company’s newsroom at https://ibn.fm/NMRD

• PlantX entered into an asset purchase agreement with Peter Rubi, LLC on December 12, 2021
• The purchase’s primary objective was to grow PlantX’s e-commerce enhancing strategy while leveraging Peter Rubi’s resources to increase revenue and market reach
• Following the purchase, PlantX has announced same-day delivery services for its products across Chicago and Plainfield, Illinois
• The company’s management is excited about the launch and what marks the beginning of other ambitious plans that PlantX has in store for this new year

On December 12, 2021, PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), through its wholly-owned subsidiary, PlantX Midwest Inc., entered into an asset purchase agreement for the acquisition of all assets for Peter Rubi, LLC, along with the assumption of some of its liabilities. The purchase agreement was to the tune of $1.2 million in cash, in addition to 9,188,897 common shares in the authorized share structure of the company, valued at $0.2774 per share. The goal with the acquisition was to grow PlantX’s e-commerce enhancing strategy while leveraging Peter Rubi’s warehousing facilities, operational potential, extensive customer base, and plant-based merchandising expertise to increase revenue within the United States (https://ibn.fm/8jaeO). In what marks a significant move since this acquisition, PlantX has launched same-day delivery services for its products across Chicago and Plainfield, Illinois. The company plans to avail these services through third-party delivery apps, in addition to retail locations within these two cities, allowing for the deployment of its e-commerce marketing expertise to these specific locations (https://ibn.fm/vJneb). PlantX also announced its plans to use data from its e-commerce site and geo-targeted marketing to engage with the Illinois communities, ultimately bringing plant-based products to more customers and making the plant-based lifestyle accessible to all. “We see this new vertical as a way to increase our customer base through our retail locations while offering customers more choices in how they shop,” noted Lorne Rapkin, the Chief Executive Officer (“CEO”) of PlantX. “Allowing customers to order products for same-day delivery through third-party delivery apps is merging PlantX’s e-commerce strengths with the company’s newer venture into retail,” he added. The Chicago location has been rebranded as XMarket Uptown, and customers will now have access to a variety of plant-based brands and products, including, but not limited to, fresh produce, PlantX’s own ready-to-eat meals, and recipes. “Providing superior quality project and same-day services for our customers in Illinois is another step toward our strategic expansion plan,” reckoned Sean Dollinger, PlantX’s founder. While announcing Peter Rubi’s acquisition, Mr. Dollinger noted the company’s influential presence in the Chicagoland area. He further acknowledged how the purchase would give PlantX access to an amazing new community in and around the third largest city in the United States, all while solidifying its e-commerce market presence and impact in the Midwestern US. PlantX’s management is excited about Peter Rubi’s acquisition. These new developments regarding same-day delivery and the rebranding of the Chicago store are only the beginning of other ambitious plans that the company has in store for this new year. For more information, visit the company’s websites at www.PlantX.com. NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

• Cepton recently revealed that it had recently entered a partnership with Fibre Based Integrations to develop a lidar-based vehicle detection solution, with the goal of furthering Cape Town’s smart transportation infrastructure
• The smart transportation solution ranks amongst one of over 100 projects which Cepton is currently pursuing, for applications of its lidar technology outside of its traditional use within autonomous vehicles
• Separately, the company announced their intention of participating in investor conferences hosted by Cowen and Berenberg in early March 2022, with the goal of updating institutional investors on their ongoing operational highlights

By most standards, Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMR(R) lidar solutions, has enjoyed an active start to life listed on the Nasdaq Exchange. Having formally commenced trading on the Nasdaq Capital Market on February 11, 2022, Cepton Inc. has announced a number of recent operational highlights in recent weeks, which include entering a partnership with Fibre Based Integrations to facilitate smart transportation infrastructure in Cape Town, South Africa whilst simultaneously, taking part in a spate of investor conferences in a bid to heighten the company’s profile amongst the institutional investors in attendance. In early March 2022, Cepton Inc. revealed that it was partnering with Fibre Based Integrations, an established fiber optics systems house, to develop a lidar-based vehicle detection system, aimed at assisting the creation of smart transportation infrastructure within South Africa’s Cape Town. The use of Cepton’s innovative lidar technology will allow the system to provide authorities with analytics designed to improve traffic flow and safety for motorists and pedestrians, alike. Based on this information, system operators will be able to ascertain how a specific intersection or piece of road is being used; more importantly, it also marks a significant diversification for Cepton away from their products’ more traditional use as an automotive sensor technology (https://ibn.fm/D3RPJ). Originally developed by NASA to measure objects in space (https://ibn.fm/e5q51), lidar technology has been widely acclaimed by the autonomous vehicle sector as a key sensor technology, with Cepton currently in discussion with all of the world’s top-10 automotive OEMs for the supply of their proprietary solution. However, and given the technology’s higher spatial resolution – which allows it to perform better than cameras and radars in various weather and lighting conditions, lidar technology has rapidly become a key enabler for smart city infrastructure solutions the world over. Josh Goosen, System Engineer at Fibre Based Integrations remarked in relation to the Cepton partnership, “The reason we chose to deploy lidars in our vehicle detection and classification systems is their superior accuracy. We found Cepton lidars to be the best performing and most accurate compared with others we tested, and this has unlocked new possibilities for implementing our smart city solutions with the City of Cape Town.” Simultaneously, Cepton Inc. also seized on the opportunity to announce that they would be attending investor conferences held by Cowen and Berenberg, respectively with a view towards updating institutional investors on the company’s ongoing operational highlights and investment thesis. In addition, the company also announced that they would be providing investors with a further business update as well as releasing their financial results for the 2021 financial year following the market close on Thursday, March 10, 2022. For more information, visit the company’s website at www.Cepton.com. NOTE TO INVESTORS: The latest news and updates relating to CPTN are available in the company’s newsroom at https://ibn.fm/CPTN

• Delic Holdings Corp, a leader in new medicines and treatments for a modern world, understands that research is integral for both the rapidly developing psychedelics and cannabis industries, and for psychedelics to be widely adopted for the treatment of mental health issues
• Dr. Markus Roggen, President and CSO of Delic Labs, recently spoke at this year’s Emerald Conference, and has reiterated the importance of leveraging AI in crafting products for the cannabis industry
• Delic is continually expanding its efforts to conduct and encourage even more research and education in support of high-quality products for more people, supporting mental health while building shareholder value

Since its inception, Delic Holdings (CSE: DELC) (OTCQB: DELCF) has remained committed to emphasizing the value of research and education in support of mental health. In addition, it has helped drive the reframing of the psychedelic conversation while being at the forefront of the ongoing psychedelics renaissance. Delic understands that research is integral if psychedelics are to be widely adopted for treating mental issues. This is further reinforced by Delic Labs, a wholly-owned subsidiary of Delic and the only licensed entity exclusively focused on research and the development of psilocybin vaporization technology in Canada. Psilocybin has proven to be an effective treatment for depression, a condition affecting 50% of Americans today, and has received approval from the United States Food and Drug Administration (“FDA”). The FDA has also approved esketamine, a fast-acting antidepressant that can reduce suicide rates which currently stand at one suicide every 40 seconds. Additionally, psilocybin has also proven useful and effective for smoking cessation, an issue that affects over 50 million people in the United States (https://ibn.fm/kKw7w). Delic’s focus on research is moving society closer to the full adoption of psychedelics for the treatment of mental health issues by pushing the narrative regarding psychedelics, their usefulness, and their potential, even beyond mental health treatment. In addition, Delic is also expanding the boundaries of how such research is conducted, particularly given its current use of Artificial Intelligence (“AI”) for crafting products for the cannabis industry. Dr. Markus Roggen, the President and Chief Science Officer (“CSO”) of Delic Labs, recently spoke at this year’s Emerald Conference held February 2022, in San Diego. Known for providing a platform for scientific communication and collaboration, this conference was an excellent avenue for Delic to share its progress and standing on psychedelics and cannabis research. Of note was Dr. Roggen’s emphasis on the importance of why leveraging AI can help increase the quality of the extract while keeping overhead at an all-time low (https://ibn.fm/dyEZg). “Focusing solely on extraction yields for cannabis extraction operations is an imprecise way to think about production,” noted Dr. Roggen. “Quality of extract, cost of extraction, and loss in post-processing should all be considered. Our laboratory undertook extensive experimental studies on the extraction behavior of various solvents, and we’re excited to present our latest results and insights from developing and utilizing our extraction optimization AI,” he added. Dr. Roggen’s research into process optimization and analytical methods has earned him several awards, including the ElSohly Award of the ACS, the 40 under 40 by Marijuana Venture Magazine, as well as the Cannabis Scientist Power List 2020 & 2021. His leadership of Delic Labs represents what Delic Holdings stands for, the value that it sees in R&D, and the potential that psychedelics hold for mental health treatment. Delic is continually expanding its efforts to conduct and encourage even more research and education in support of high-quality products for the masses. By doing so, the company generates shareholder value as well as effective solutions for those struggling with mental health issues. For more information, visit the company’s website at www.DelicCorp.com. NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF

• INND expands availability of its offering through Walmart Canada, its flagship online store
• Leveraging its successful relationship with the North American retail heavyweight, INND aims to deliver on its ambitious growth potential
• Through Walmart.ca, INND will be able to reach 1.5 million customers that visit this e-Commerce platform daily

InnerScope Hearing Technologies (OTC: INND), a leading Direct-to-Consumer disruptor in the hearing aid technology space, appears uncompromised in its readiness to accelerate its growth trajectory in the time to come. The company announced that some of its HearingAssist and iHear hearing products and related supplies would be available for purchase on Walmart.ca, with a view to increasing its offering on the platform over the coming weeks (https://ibn.fm/0WqLa). As a verified wholesaler with Walmart for premium affordable direct-to-consumer hearing products, INND appears well-positioned to leverage the relationship established with this major retailer to solidify its presence in the growing North American market. The company’s wholly owned subsidiary, HearingAssist, is already considered Walmart’s largest direct-ship and wholesale hearing aid supplier. Direct-to-Consumer (“DTC”) space has seen rapid growth since the start of the pandemic, leading to the retail titan doubling down on online selling. As a result, its online platform Walmart.ca appears to be a thriving place as it attracts an increasing number of consumers – in 2021, its e-Commerce sales grew at the rate of 11% year over year and at a staggering 90% compared with two years ago (https://ibn.fm/rj6VJ). Given the estimates that around 65% of Canadians older than 70 years suffer from hearing loss while more than half of those between 40 and 79 have at least mild hearing impairment, expansion into this geographical direction appears to be a natural evolution of INND’s expansion strategy. Since 77% of them are not aware that they suffer from hearing impairment, many don’t seek help from a Registered Audiologist or Registered Hearing Aid Practitioner, which presents a vast unexplored market INND can tap into. Reaching this sizeable addressable market through Walmart’s Canadian e-Commerce platform could potentially take INND’s market position to new heights. Having access to Walmart’s flagship Canadian online store to serve as a launchpad for the company’s Canadian expansion can be a considerable advantage as INND will be able to offer its unique hearing products and related supplies to more than 1.5 million customers that visit the Walmart.ca website daily. Matthew Moore, President and CEO of InnerScope Hearing Technologies, is enthusiastic about the company’s latest move. “We look forward to continuing to build and expand our relationship with Walmart through InnerScope’s subsidiary HearingAssist, America’s number-one affordable hearing aid brand and currently Walmart’s largest hearing aid supplier. We believe InnerScope, with its growing market presence and footprint, is leading the way for delivering affordable hearing healthcare in-store or right to consumers’ homes through major retailers.”, he said when announcing the company’s Canadian e-Commerce launch. For more information, visit the company’s website at www.INND.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

• Friendable has seen consistent growth since the beginning of 2022 with the acquisition of Artist Republik and FeaturedX
• Overall, social engagements for the company increased by 65% for the month of February
• In the future, Friendable plans to expand its unique 360 artist offering to include the Metaverse and NFTs
• The global music distribution services market is expected to reach $1.68 billion by 2030

Friendable (OTC: FDBL), a mobile technology and marketing company, is pleased with the month-over-month growth of its 360-artist offering, announcing increases and trend specific indicators in revenue, distribution orders, and key social metrics that contribute to the growth of the company through its flagship offering, Fan Pass Live artist platform, along with the recent acquisition Artist Republik and FeaturedX. The report refers to February metrics and shows the second month of consistent growth since the acquisition of Artist Republik. Robert A. Rositano, Jr., CEO of Friendable, commented on these growth metrics, underlining that the combination of service offerings expanding, web properties and mobile apps being updated and sustained integration efforts to make sure all brands and services are clearly represented, has proven to be a winning strategy (https://ibn.fm/uDCop). “We have focused on the building blocks of a successful foundation, allowing our operations teams to execute as our sales and awareness continue to grow,” Rositano Jr. explained. “The increases below are truly a testament to our team’s continued persistence to be the only and best 360 music artist platform for products, services, livestream, fan engagement, artist revenue growth, and overall launch points for their music careers.” The company reported key metrics and trending growth indicators as they applied to Fan Pass Live’s Twitter, Instagram, and Facebook for February:

• Overall engagements increased by 65% for the month
• Social impressions saw an increase of 5.6%
• Total engagements increased 65.3%
• The total audience increased 14.2%
• Total net audience growth is up 17.5%
• Twitter net follower growth is up 62.5%
• Instagram net follower growth increased 57.3%
• Total social impressions increased 5.6%
• Twitter impressions saw an increase of 197.7%
• Facebook impressions increased 10.2%
• Total engagement increased by 65.3%
• Twitter engagement increased by 99.1%
• Facebook engagement was up 70.8%
• Instagram engagement increased 17.4%
• Overall engagement rate (per impression) is 56.4%
• Average Revenue Per Day – up 4% organically/pending marketing launch
• Music Tracks Distributed – 132% increase currently – March 2022

The company intends to keep positive growth a key factor going forward. Rositano, Jr. explained that as artists, fans, brands, labels, agents, managers, studios, venues, booking advisors, and partners of all sizes have begun to take notice of Friendable’s 360 platform and technology infrastructure, “our offerings have seen increased traction on all fronts, proving out the highly repeatable and consumable nature of our product and service offerings.” The company is now beginning to engage opportunities to acquire ‘Metaverse’ real estate for future virtual events as well as finalize its non-fungible token offering to complement its 360 strategies, resulting in its artist members quickly becoming repeat buyers, as evidenced by the company’s positive revenue growth, brand awareness, and social engagement metrics across the board,” Rositano Jr. added. These metrics and the comprehensive offering Friendable provides, can help position the company in a leading role on the global music distribution services market. This sector generated $911.87 million in revenue in 2020, and is expected to reach $1.68 billion by 2030, growing at a CAGR of 6.2% during the forecast period of 2021 through 2030 (https://ibn.fm/dATMX). Based on the research, the artist-to-fan segment accounted for the highest share in 2020, taking up approximately three-fifths of the global music services market. This segment is expected to grow on its own at a CAGR of 6.9% from 2021 through 2030. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• A “bear run” in California’s volatile wholesale cannabis market may be over
• “A wholesale turnaround would be welcome news for thousands of growers across the state
• SGMD operates Nug Avenue, a cannabis delivery service located in the Los Angeles metropolitan area

As wholesale cannabis prices increase in California, cannabis companies operating in the state are already seeing improvement (https://ibn.fm/HCYdn). One of those companies, Sugarmade (OTC: SGMD), has set its eyes on expanding its end-market access as a central player in the growing California cannabis delivery marketplace while also developing its in-house cannabis production capacity to verticalize operations in the space. “A bear run in California’s volatile wholesale cannabis market appears to be over,” reported an MJBizDaily article announcing that California wholesale cannabis prices were rebounding. “The price of bulk flower — which hit rock bottom in November and squeezed growers financially — is starting to rebound amid an uptick in sales, according to several operators who told MJBizDaily they closed the books last month on a high note. “A wholesale turnaround would be welcome news for thousands of growers across the state, from craft producers in the Emerald Triangle to some of the nation’s largest cultivators in Santa Barbara County,” stated the article, which noted that prices began to drop nearly a year ago. “In addition to falling prices, many growers have been struggling because of a thriving underground market, high taxes and a limited number of retail outlets for their product.” The article quotes several growers who reported seeing “a modest rise in wholesale pricing” in January, which is in line with traditional seasonal spikes after big outdoor harvests that flood the market in October and November. “The average price per pound of cannabis flower is up to about $750 to $1,100 for quality, big buds and $300-$450 for smalls. . . . . That’s a nice bump from November, when prices bottomed out at roughly $400 per pound for AAA-grade flower amid a glut of marijuana.” In the article, cannabis operators noted that they were seeing an increase in pricing and uptick in sales, which is very promising entering the new yea; the article also observed that consumer demand was driving higher-quality product. Sugarmade currently operates Nug Avenue, a cannabis delivery service located in the Los Angeles metropolitan area. The location opened in March 2021 and by the end of June 2021, it had more than 10,000 unique members (https://ibn.fm/1lZLa). That growth has continued, and the company now has nearly 25,000 unique members, with plans for a second location underway and other locations being explored. In addition, SGMD has implemented new cannabis delivery technology to establish a competitive advantage in its core delivery zone: the Onfleet last-mile delivery solution with Blaze. And Sugarmade is finalizing plans for its first planting at the large 640-acre outdoor cultivation site associated with its recently acquired Lemon Glow subsidiary; the company believes all necessary approvals will be in place in time for the 2022 planting season. Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s portfolio includes CarryOutsupplies.com, SugarRush(TM), NUG Avenue, Lemon Glow and Budcars. For more information, visit the company’s website at www.Sugarmade.com. NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SGMD

The Microdose Psychedelics Capital Conference virtual event will commence on Thursday, March 24, 2022, 1:30 EST, and investors, family officers, budding entrepreneurs, psychedelic researchers, medical & science specialists and health professionals are invited to attend. The agenda of the conference will include discussions, keynotes, and insights from world-class speakers, top companies, as well as the latest IPOs, all addressing the potential and scope of investments in the psychedelic sector. The conference will explore specific opportunities in the psychedelic investment sector, along with discussions on the latest innovations in drug development, pertinent laws and regulations, and business trends. This virtual event is a part of the bi-monthly investor series that explores the immense scope of psychedelic investment and connects new businesses to the leading capital industries and investors of the psychedelic arena. The conference is organized by Microdose, a premier organization focused on creating, offering and distributing the most compelling content on the finance, industry news, science, and the latest breakthroughs and events of the psychedelic industry. This is a robust platform offering exposure to professionals, companies, and individuals about the events of the psychedelic industry. This PsyCap event will focus on topics like corporate social responsibility (“CSR”), environmental, social and governance (“ESG”), market consolidation, and explore the possibilities of a potential investment. The Doing Good segment of Psychedelic Capital features presentations from a non-profit organization from the industry. At this event, the PsyCap Doing Good presentation is hosted by the World Happiness Foundation. The introduction of the Microdose event will be given by:

• Patrick Moher, President, Microdose Psycheledics Insights, is a young entrepreneur dedicated to creating unique business opportunities across the social and economic spectrum for budding industries and individuals. 
• Richard Skaife, Chair, Microdose, The Conscious Fund, a veteran in mental health technology and investment

The virtual conference will feature corporate presentations from industry veterans like Clearmind Medicine and Med Plant Science, and offers a unique opportunity for growing companies to connect with peers and industry leaders. Investors can gain access to phenomenal pre-IPO investments opportunities across the psychedelic sector. The Microdose Group’s first investment opportunity is with HIVE Bio which has partnered with Med Plant Science Ltd to enable safe and legal access of psychedelics medicine to patients. Med Plant Science Ltd, is a biotech company focused on developing psychedelic products, from plants and mushrooms. To learn more, please visit https://ibn.fm/t47sm.